QMC Receives Drill Permit for the Irgon Lithium Mine Project
Mar 14, 2018 12:45 pm UTC| Business
VANCOUVER, British Columbia, March 14, 2018 -- QMC Quantum Minerals Corp., (TSX.v: QMC) (FSE: 3LQ) (OTC PINK: QMCQF) (“QMC” or "the Company"). QMC is pleased to report that it has received a drill permit from the...
Black Knight Announces Pricing of Secondary Offering of Common Stock and Repurchase of Common Stock
Mar 14, 2018 12:38 pm UTC| Business
JACKSONVILLE, Fla., March 14, 2018 -- Black Knight, Inc. (NYSE:BKI) (the “Company” or “Black Knight”), a leading provider of software, data and analytics solutions to the mortgage and consumer loan, real estate and...
PyroGenesis is Nominated for “Materials Company of the Year” at the 3D Printing Industry Awards 2018
Mar 14, 2018 12:35 pm UTC| Business
MONTREAL, March 14, 2018 -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR), (the "Company", the “Corporation” or "PyroGenesis") a Company that designs, develops and manufactures plasma waste-to-energy...
Mar 14, 2018 12:31 pm UTC| Business
VALLEY COTTAGE, New York, March 14, 2018 -- Manufacturers across industries are focusing on new product development and product enhancement to grab major hold in the global market. Different types of products are being...
Sipp Industries Reports Better Than Expected Sales of Major Hemp Brown Ale
Mar 14, 2018 12:31 pm UTC| Business
COSTA MESA, Calif., March 14, 2018 -- via OTC PR WIRE--Sipp Industries, Inc. (OTC:SIPC), a multifaceted corporation specializing in technology, manufacturing, and distribution of commercial and consumer products...
Epazz Social Media Blockchain Decentralized Platform to Be Released on June 30
Mar 14, 2018 12:31 pm UTC| Business
CHICAGO, March 14, 2018 -- Epazz, Inc. (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that the company will release its social media...
iBio Selects Lead Candidate for its Fibrosis Therapeutics Program
Mar 14, 2018 12:31 pm UTC| Business
NEW YORK, March 14, 2018 -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio”) announced today that it had selected an E4-Fc fusion protein as its lead candidate for further development of a drug against fibrotic diseases,...